# US 2021/0069372 A1 · Molecular sieve/fiber composite material and preparation method thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0069372 A1
- Document ID: US20210069372A1
- Status: Published application
- Kind: A1
- Application number: 17/042,128
- Filed: 2019-04-16
- Published: 2021-03-11
- Earliest claimed: 2018-06-18
- Assignees: Zhejiang University
- Applicants: Zhejiang University
- Inventors: Jie Fan; Lisha Yu; Liping Xiao; Hao Chen; Xiaoqiang Shang
- Web page: https://patentgrep.com/patent/US20210069372A1

## CPC

- A61L 24/0089: {containing inorganic fillers not covered by groups A61L24/0078 or A61L24/0084}
- D06M 23/08: Processes in which the treating agent is applied in powder or granular form (adhesives for multi-layer textile fabrics D06M17/00)
- A61K 31/7088: Compounds having three or more nucleosides or nucleotides
- A61K 31/715: Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K 31/74: Synthetic polymeric materials
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61L 15/18: containing inorganic materials
- A61L 15/40: containing ingredients of undetermined constitution or reaction products thereof {, e.g. plant or animal extracts}
- A61L 15/42: Use of materials characterised by their function or physical properties (liquid bandages A61L26/00)
- A61L 15/44: Medicaments
- A61L 15/46: Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
- A61L 17/005: {containing a biologically active substance, e.g. a medicament or a biocide}
- A61L 17/10: containing macromolecular materials
- A61L 24/0031: {Hydrogels or hydrocolloids}
- A61L 24/0036: {Porous materials, e.g. foams or sponges}
- A61P 7/04: Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- B01D 53/02: by adsorption, e.g. preparative gas chromatography {(solid sorbent compositions B01J20/00, preparation of inorganic compounds or elements C01)}
- B01J 20/18: Synthetic zeolitic molecular sieves
- B01J 20/24: Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
- B01J 20/28004: {Sorbent size or size distribution, e.g. particle size}
- B01J 20/28007: {with size in the range 1-100 nanometers, e.g. nanosized particles, nanofibers, nanotubes, nanowires or the like (carbon nanostructures B01J20/205)}
- B01J 20/28028: {Particles immobilised within fibres or filaments}
- B01J 20/28057: {Surface area, e.g. B.E.T specific surface area}
- C02F 1/288: {using composite sorbents, e.g. coated, impregnated, multi-layered}
- C08L 1/286: {substituted with acid radicals, e.g. carboxymethyl cellulose [CMC] (C08L1/282 takes precedence)}
- C08L 5/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- D06M 11/79: with silicon dioxide, silicic acids or their salts
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61L 2300/44: Radioisotopes, radionuclides
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- B01D 2253/108: Zeolites
- B01D 2253/116: Molecular sieves other than zeolites
- B01D 2253/25: Coated, impregnated or composite adsorbents
- B01D 2253/304: Linear dimensions, e.g. particle shape, diameter
- B01D 2258/06: Polluted air
- C02F 1/42: by ion-exchange (ion-exchange in general B01J)
- C02F 2305/04: Surfactants, used as part of a formulation or alone
- C02F 2305/08: Nanoparticles or nanotubes
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- D06M: TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C02F: TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE (separation in general B01D; special arrangements on waterborne vessels of installations for treating water, waste water or sewage, e.g. for producing fresh water, B63J; adding materials to water to prevent corrosion C23F; treating radioactively-contaminated liquids G21F9/04; regeneration of reactants for recirculation into processes, see the relevant places for the processes)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

The disclosure provides a molecular sieve/fiber composite material comprising molecular sieves and a fiber, the molecular sieves are distributed on the fiber surface and directly contact the fiber surface; the particle diameter D90 of the molecular sieves is 0.01 to 50 μm, the particle size D50 of the molecular sieves is 0.005 to 25 μm; the molecular sieves are distributed uniformly on the fiber surface of the fiber. The disclosure also provides a preparation method for the molecular sieve/fiber composite material and various applications. The molecular sieve/fiber composite material has high strength, elastic recovery ability, and dimensional stability, making the composite material strong and durable. The molecular sieve/fiber composite material has a simple structure, low cost, strong stability, high repeatability of performance, and high practical efficiency, and provides the application in the fields of hemostasis, beauty, deodorization, sterilization, water purification, air purification, and radiation resistance.

## Claims

### Claim 1

A molecular sieve/fiber composite material comprising molecular sieves and a fiber, the molecular sieves are distributed on the fiber surface and directly contact the fiber surface;
a first particle diameter D90 of the molecular sieves is 0.01 to 50 μm, second particle size D50 of the molecular sieves is 0.005 to 30 μm;
the molecular sieves are distributed uniformly on a fiber surface of the fiber; the uniform distribution of the molecular sieves on the fiber surface is detected by the method of: randomly taking n samples of the molecular sieve/fiber composite material at different locations, and analyzing a content of the molecular sieve on the fiber surface, where n is a positive integer greater than or equal to 8, a coefficient of variation of the content of the molecular sieves in the n samples is ≤15%.

### Claim 2 (depends on 1)

The molecular sieve/fiber composite material of claim 1, wherein a first surface of the molecular sieve contacted with the fiber is defined as an inner surface, and the inner surface is a planar surface matched with the fiber surface; a growth-matched coupling is formed between the molecular sieve and the fiber on the inner surface of the molecular sieve; a second surface of molecular sieve uncontacted with the fiber is defined as an outer surface, and the outer surface is a non-planar surface.

### Claim 3 (depends on 2)

The molecular sieve/fiber composite material of claim 2, wherein a detection method for forming a growth-matched coupling is performed in conditions as follows: the retention rate of the molecular sieve on the fiber is greater than or equal to 90% under ultrasonic condition for 20 minutes or more.

### Claim 4 (depends on 2)

The molecular sieve/fiber composite material of claim 2, wherein the inner surface and the outer surface are composed of molecular sieve nanoparticles.

### Claim 5 (depends on 4)

The molecular sieve/fiber composite material of claim 4, wherein the average size of the molecular sieve nanoparticles of outer surface is larger than the average size of the molecular sieve nanoparticles of inner surface.

### Claim 6 (depends on 1)

The molecular sieve/fiber composite material of claim 1, wherein the molecular sieves are independently dispersed on the fiber surface.

### Claim 7 (depends on 6)

The molecular sieve/fiber composite material of claim 6, wherein the independent dispersion refers that the minimum distance between the molecular sieve microparticle and the nearest molecular sieve microparticle is greater than or equal to one half of the sum of the particle sizes of the two molecular sieve microparticles.

### Claim 8 (depends on 4)

The molecular sieve/fiber composite material of claim 4, wherein the average size of the molecular sieve nanoparticles of the inner surface is 2 to 100 nm.

### Claim 9 (depends on 4)

The molecular sieve/fiber composite material of claim 4, wherein the average size of the molecular sieve nanoparticles of the outer surface is 50 to 500 nm.

### Claim 10 (depends on 1)

The molecular sieve/fiber composite material of claim 1, wherein the molecular sieve is selected from the group consisting of aluminosilicate molecular sieve, phosphate molecular sieve, borate molecular sieve, heteroatom molecular sieve, and combination thereof.

### Claim 11 (depends on 1)

The molecular sieve/fiber composite material of claim 1, wherein the molecular sieve is a molecular sieve after metal ion exchange.

### Claim 12 (depends on 11)

The molecular sieve/fiber composite material of claim 11, wherein the metal ion is selected from the group consisting of strontium ion, calcium ion, magnesium ion, silver ion, zinc ion, barium ion, potassium ion, ammonium ion, copper ion, and combination thereof.

### Claim 13 (depends on 1)

The molecular sieve/fiber composite material of claim 1, wherein the fiber is a polymer containing hydroxyl groups in a repeating unit.

### Claim 14 (depends on 1)

The molecular sieve/fiber composite material of claim 1, wherein the fiber is selected from the group consisting of silk fiber, chitin fiber, rayon fiber, acetate fiber, carboxymethyl cellulose, bamboo fiber, cotton fiber, linen fiber, wool, wood fiber, lactide polymer fiber, glycolide polymer fiber, polyester fiber, polyamide fiber, polypropylene fiber, polyethylene fiber, polyvinyl chloride fiber, polyacrylonitrile fiber, viscose fiber, and combination thereof.

### Claim 15 (depends on 1)

A preparation method for a molecular sieve/fiber composite material of claim 1, wherein the preparation method is an in-situ growth method, and the in-situ growth method comprises the following steps:
(i) preparing a molecular sieve precursor solution and mixing the molecular sieve precursor solution with a fiber to obtain a mixture of the fiber and the molecular sieve precursor solution;
(ii) processing the mixture of the fiber and the molecular sieve precursor solution obtained in step (i) with heat treatment to obtain the molecular sieve/fiber composite material.

### Claim 16 (depends on 15)

The preparation method of claim 15, wherein the fiber is not subjected to pretreatment and/or no adhesives have been added; the pretreatment refers to a treatment method that destroys fiber structure of the fiber.

### Claim 17 (depends on 15)

The preparation method of claim 15, wherein the molecular sieve precursor solution does not include a templating agent.

### Claim 18 (depends on 15)

The preparation method of claim 15, wherein in the step (ii), a temperature of the heat treatment is 60 to 220° C., and a time of heat treatment is 4 to 240 h.

### Claim 19 (depends on 15)

The preparation method of claim 15, wherein the molecular sieve is a mesoporous molecular sieve.

### Claim 20 (depends on 1)

A compound, wherein the compound comprises the molecular sieve/fiber composite material according to any one of claim 1.

### Claim 21 (depends on 20)

The compound of claim 20, wherein the compound is a hemostatic material.

### Claim 22 (depends on 20)

The compound of claim 20, wherein the compound comprises an additive.

### Claim 23 (depends on 22)

The compound of claim 22 wherein the additive is selected from the group consisting of metal, metal ion-containing compound, synthetic polymer compound, poorly soluble polysaccharide, protein, nucleic acid, pigment, antioxidant, mold inhibitor, detergent, surfactant, antibiotic, antibacterial agent, antimicrobial agent, anti-inflammatory agent, analgesic agent, antihistamine, and combination thereof.

### Claim at position 24

24-82. (canceled)
